Want to learn more about #CD4 #Tcells? Read our open access recent review by lead author Marco Kuenzli! nature.com/articles/s4159…

Woot woot! 🎉 Super happy to see Ingunn acknowledged as the excellent professor she is. Time to celebrate!

Stromnes lab’s almond gourmand competition went splendidly! Thanks to all the judges and CFI friends who enjoyed our pastries. The winner: Grant Hickok’s king’s cake! Runner ups are Zoe’s quadruple nut scones and Eddie’s triple almond tart. So fun!

New Cell Reports paper by our group + Jesse Williams Lab. Pancreatic cancer anti-tumor immunity relies on tumor-specific CD4+ T cells steering the macrophage population to an anti-tumor phenotype. Hugely collaborative paper that turned out great! Read here: cell.com/cell-reports/f…

Congrats to Eddie (Eddie Cruz) for being award a CFI Immunology Training T32 Fellowship! 🎉 Congrats to the other MICaB trainees who also received the fellowship! med.umn.edu/immunology/res…

Stromnes lab graduate students had an awesome time at this year's MICaB camping trip. As always, lots of games, friends, and s'mores! Great recharge for the semester ahead! 🚣

Congratulations to Dr. Natalie David on her successful defense: "Nuclear corepressors NCOR1 and NCOR2 in CD4 T cell development" Advisor: Mike Farrar #CFIproud

Already missing the fall colors at this year’s Center for Immunology Conference in Duluth 🍂 Always a fantastic time to convene with our colleagues and learn about the great science going on at the CFI!

The MX Biobank paper is out today in nature! This is the first national-scale genomic database in Mexico and the largest independent project led by my lab Cinvestav since I returned to my home country to help building local capacity. rdcu.be/dojZ5

and who doesn't like a good pun 🙊

Eddie Cruz presented an update on his thesis project at today's MICaB student seminar. Great job and beautiful immunofluorescent images!

1/Excited to share our latest work published in Cancer Discovery. Led with #MiyaHugaboom, #KellyStreet, we show that the presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in #RCC patients: brnw.ch/21wQUU4

🚨New paper alert🚨 Work led by Zoe Schmiechen found that combination CD40 + PD-L1 expands antigen specific T cells. Adding IL-15C prolonged survival, generated lasting immune memory, and drove effector T cell phenotype. Read here: aacrjournals.org/cancerimmunolr…

🔬 The Stromnes Lab Stromnes Lab at UMN engineers T cells to target tough-to-treat pancreatic cancer. Part of the Center for Genome Engineering, they're pushing the limits of immunotherapy. sites.google.com/umn.edu/stromn… #CancerResearch #Immunotherapy #GenomeEngineering

Hello #AAI2025 ! Want to learn about how T cell receptor strength dictates CD8 T cell funtion? Grant is presenting his research on CD8 T cell clones with varying TCR strength and how it leads to differing responses in a murine model of pancreatic cancer. See you tomorrow!

🤩

The shirt is super breathable too 😆

Dr. Branden Moriarity (Center for Genome Engineering) was on WCCO yesterday to speak about Tumor Infiltrating Lymphocyte therapy, a powerful approach showing real promise, for advanced solid tumor cancers ➡️: cbsn.ws/4oe9irE. Join an upcoming webinar to learn more ➡️: med.umn.edu/cge/til

🧬 Wondering what the future holds for T cell cancer therapies? We wrote an editorial for Science Magazine about how AI—like AlphaFold—is accelerating the design of T cell receptors (TCR), powering the next-generation of anti-tumor therapies. Read here! science.org/doi/10.1126/sc…

CD4+ T Helper Cells Play a Key Role in Maintaining Diabetogenic CD8+ T Cell Function in the Pancreas: Gabriel Espinosa-Carrasco, Cécile Le Saout, Pierre Fontanaud, Thomas Stratmann, Patrice Mollard, Marie Schaeffer, Javier Hernandez goo.gl/4txuvU